A COMPARATIVE STUDY TO EVALUATE THE EFFICACY OF AGNIKARMA(THERMAL CAUTERY) WITH AND WITHOUT INTERNAL ADMINISTRATION OF ERANDA TAILA IN VATAKANTAKA W.S.R TO CALCANEAL SPUR
Keywords:Eranda taila, vatakantaka, Calcaneal Spur, Agnikarma
Background: Vatakantaka/Calcaneal Spur is a common cause of heel pain with peak incidence between 40 to 60 yrs of age. Calcaneal treated by measures that decrease the associated inflammation and reinjury.Anti inflammatory and analgesics medications are often hepful.But they relieved pain temporarily, hence we need a permanent curative treatment for the condition. Objectives: To Evaluate the Efficacy of Agnikarma with and without Eranda Taila Pana in Vatakantaka W.S.R to Calcaneal Spur. Methods: 60 patients of Vatakantaka were selected and randomly divided into two equal groups consisting of 30 patients each as Group-A and Group-B. Group-A- were subjected to Agnikarma at the maximum tender point in Bindu Akrithi (dot) shaped pattern with Panchaloha Salaka for a single sitting. Group-B- were subjected to Agnikarma at the maximum tender point in dot shaped pattern with Panchaloha Salaka for a single sitting along with Eranda taila pana(10 ml) in the early morning on empty stomach with warm water for 7 consecutive days. Subjective parameter- Ruk, Thoda, Sthambha Objective parameters - Kriyahani , Sparshasahishnutwa . These were suitably graded to assess the result based on clinical observations. Statistical test were applied to analyse the result. For comparing between the groups Mann-Whitney U Test using SPSS Statistics is done Wilcoxon Sign Rank Test was done for analysing the different of significant change. DISCUSSION: There was a significant difference amoung the result of treatment among Group A and Group B with test significance p<0.001.The percentage of success of Group A was 69.7% and Group B was 96.1%. CONCLUSION: Group B showed better result than Group A. Combination of Agnikarma and internal administration of Eranda taila mentioned in Vatakantaka is more effective than Agnikarma alone with low recurrence rate.
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.